{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:26Z","timestamp":1786119386776,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11,27]]},"DOI":"10.1097\/qad.0b013e3283326879","type":"journal-article","created":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T03:16:15Z","timestamp":1257822975000},"page":"2485-2495","source":"Crossref","is-referenced-by-count":30,"title":["Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina"],"prefix":"10.1097","volume":"23","member":"276","reference":[{"issue":"3","key":"R1-14-20210130","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1164\/ajrccm.162.3.9908018","article-title":"Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD","volume":"162","author":"Kirk","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-14-20210130","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1086\/424676","article-title":"Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy","volume":"190","author":"Dheda","year":"2004","journal-title":"J Infect Dis"},{"key":"R3-14-20210130","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","article-title":"Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America","volume":"41","author":"Girardi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R4-14-20210130","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1086\/498308","article-title":"Incidence of tuberculosis during highly active antiretroviral therapy in high-income and low-income countries","volume":"41","author":"Lawn","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1468-1293.2008.00567.x","article-title":"Tuberculosis-HIV co-infection: policy and epidemiology in 25 countries in the WHO European region","volume":"9","author":"Lazarus","year":"2008","journal-title":"HIV Med"},{"key":"R9-14-20210130","first-page":"903","article-title":"Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia","volume":"7","author":"Morozova","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1183\/09031936.98.12020505","article-title":"Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients","volume":"12","author":"Veen","year":"1998","journal-title":"Eur Respir J"},{"key":"R12-14-20210130","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"R13-14-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-149-2-200807150-00008","article-title":"Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis","volume":"149","author":"Lew","year":"2008","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"R14-14-20210130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1468-1293.2005.00293.x","article-title":"BHIVA treatment guidelines for tuberculosis (TB)\/HIV infection 2005","volume":"6","author":"Pozniak","year":"2005","journal-title":"HIV Med"},{"key":"R15-14-20210130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-14-20210130","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","article-title":"Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection","volume":"14","author":"Girardi","year":"2000","journal-title":"AIDS"},{"key":"R17-14-20210130","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugpo.2007.02.010","article-title":"Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002\u20132004","volume":"18","author":"Donoghoe","year":"2007","journal-title":"Int J Drug Policy"},{"key":"R21-14-20210130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"issue":"Suppl 1","key":"R22-14-20210130","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1086\/518655","article-title":"Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome","volume":"196","author":"McIlleron","year":"2007","journal-title":"J Infect Dis"},{"key":"R23-14-20210130","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/S0140-6736(07)61262-8","article-title":"Tuberculosis","volume":"370","author":"Maartens","year":"2007","journal-title":"Lancet"},{"key":"R25-14-20210130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(08)70260-3","article-title":"Extensively drug-resistant tuberculosis","volume":"9","author":"Jassal","year":"2009","journal-title":"Lancet Infect Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200911270-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:07:42Z","timestamp":1786039662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200911270-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,27]]},"references-count":18,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283326879","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11,27]]}}}